Dukosi is a pioneering developer of cell monitoring and battery management technology, offering cutting-edge solutions for…
Category: News Headlines
View the latest news and breaking news today
AFRICA OIL ANNOUNCES RESULTS OF SHARE BUYBACK PROGRAM
VANCOUVER, BC, Jan. 22, 2024 /CNW/ – (TSX: AOI) (Nasdaq-Stockholm: AOI) – Africa Oil Corp. (“Africa Oil”, or the “Company”) is pleased…
AFRICA OIL ANNOUNCES FINAL APPROVAL FOR AN INCREASE OF ITS INTEREST IN THE ORANGE BASIN BLOCK 3B/4B
VANCOUVER, BC, Jan. 22, 2024 /CNW/ – (TSX: AOI) (Nasdaq-Stockholm: AOI) – Africa Oil Corp. ( “Africa Oil”, or the “Company”) is…
House of Rohl® Welcomes New Brands and Expands Luxury Offerings for Endless Design Possibilities at IDS Toronto 2024
New brand introductions and latest launches reinforce the House of Rohl brand commitment to artistry, curation…
Haivision Announces Results for the Three Months and Full Year Ended October 31, 2023
Haivision continues to increase gross margins, improves operational efficiency while delivering 11.3% year over year revenue…
Galaxy Asset Management: December 2023 Month End AUM
NEW YORK, Jan. 17, 2024 /CNW/ – Galaxy Digital Holdings Ltd. (TSX: GLXY) (“Galaxy”) announced that its affiliate, Galaxy Asset…
Removing barriers to build more homes, faster in Guelph, Ontario
GUELPH, ON, Jan. 12, 2024 /CNW/ – Right now, in communities across the country, building the housing we…
Intact Financial Corporation provides update on catastrophe events in the fourth quarter
TORONTO, Jan. 12, 2024 /CNW/ – Intact Financial Corporation (TSX: IFC) today provided an update on catastrophe losses…
BLACK SWAN GRAPHENE ANNOUNCES DEVELOPMENT AGREEMENT BETWEEN NERD AND ROGER BULLIVANT, A VINCI GROUP COMPANY
TORONTO, Jan. 9, 2024 /CNW/ – Black Swan Graphene Inc. (“Black Swan“) (or the “Company“) (TSXV: SWAN) (OTCQB:…
Menarini Group and Insilico Medicine Enter Global Exclusive License Agreement for Novel KAT6 Inhibitor for Potential Breast Cancer Treatment and Other Oncology Indications
KAT6 is an emerging target in hormone sensitive breast tumors and other cancers. Overexpression of KAT6A/B correlates…